ScandiDos AB (ST:SDOS) — Market Cap & Net Worth
Market Cap & Net Worth: ScandiDos AB (SDOS)
ScandiDos AB (ST:SDOS) has a market capitalization of $6.01 Million (Skr55.87 Million) as of May 4, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #27991 globally and #623 in its home market, demonstrating a -0.51% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ScandiDos AB's stock price Skr0.98 by its total outstanding shares 57011087 (57.01 Million). Analyse cash efficiency ratio of ScandiDos AB to see how efficiently the company converts income to cash.
ScandiDos AB Market Cap History: 2015 to 2026
ScandiDos AB's market capitalization history from 2015 to 2026. Data shows change from $46.96 Million to $6.01 Million (-14.30% CAGR).
Index Memberships
ScandiDos AB is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
First North Sweden PI
FNSESEKPI
|
$14.99 Billion | 0.04% | #186 of 281 |
Weight: ScandiDos AB's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
ScandiDos AB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ScandiDos AB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.12x
ScandiDos AB's market cap is 0.12 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $28.65 Million | $33.58 Million | -$14.24 Million | 0.85x | N/A |
| 2017 | $50.20 Million | $47.41 Million | -$13.16 Million | 1.06x | N/A |
| 2018 | $19.96 Million | $50.57 Million | -$11.56 Million | 0.39x | N/A |
| 2019 | $22.03 Million | $48.82 Million | -$17.76 Million | 0.45x | N/A |
| 2020 | $25.58 Million | $57.27 Million | -$13.13 Million | 0.45x | N/A |
| 2021 | $17.79 Million | $59.99 Million | -$1.40 Million | 0.30x | N/A |
| 2022 | $14.72 Million | $57.68 Million | -$7.34 Million | 0.26x | N/A |
| 2023 | $12.45 Million | $61.55 Million | -$9.12 Million | 0.20x | N/A |
| 2024 | $11.04 Million | $60.43 Million | -$14.65 Million | 0.18x | N/A |
| 2025 | $7.30 Million | $60.43 Million | -$14.65 Million | 0.12x | N/A |
Competitor Companies of SDOS by Market Capitalization
Companies near ScandiDos AB in the global market cap rankings as of May 4, 2026.
Key companies related to ScandiDos AB by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #141 globally with a market cap of $155.56 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #208 globally with a market cap of $112.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #230 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #236 globally with a market cap of $102.56 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #141 | Abbott Laboratories | NYSE:ABT | $155.56 Billion | $89.46 |
| #208 | Stryker Corporation | NYSE:SYK | $112.79 Billion | $294.73 |
| #230 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #236 | Medtronic PLC | NYSE:MDT | $102.56 Billion | $80.00 |
ScandiDos AB Historical Marketcap From 2015 to 2026
Between 2015 and today, ScandiDos AB's market cap moved from $46.96 Million to $ 6.01 Million, with a yearly change of -14.30%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr6.01 Million | -17.65% |
| 2025 | Skr7.30 Million | -33.89% |
| 2024 | Skr11.04 Million | -11.33% |
| 2023 | Skr12.45 Million | -15.42% |
| 2022 | Skr14.72 Million | -17.24% |
| 2021 | Skr17.79 Million | -30.46% |
| 2020 | Skr25.58 Million | +16.16% |
| 2019 | Skr22.03 Million | +10.33% |
| 2018 | Skr19.96 Million | -60.23% |
| 2017 | Skr50.20 Million | +75.21% |
| 2016 | Skr28.65 Million | -38.99% |
| 2015 | Skr46.96 Million | -- |
End of Day Market Cap According to Different Sources
On May 3rd, 2026 the market cap of ScandiDos AB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $6.01 Million USD |
| MoneyControl | $6.01 Million USD |
| MarketWatch | $6.01 Million USD |
| marketcap.company | $6.01 Million USD |
| Reuters | $6.01 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About ScandiDos AB
ScandiDos AB (publ), together with its subsidiaries, provides measurement phantoms and software solutions for the quality assurance and validation of dynamic and modulated treatments adopted in clinics in the United States, Europe, Asia, and internationally. The company offers Delta4 products comprising Delta4 Phantom+, Delta4Phantom+MR, Delta4 HexaMotion, Delta4Insight, Delta4DVH Anatomy, Delta4… Read more